Panzim forte - instructions for use, dose, side effects, contraindications

Excipients: microcrystalline cellulose, aerosil, sodium starch glycolate, magnesium stearate, Eudragit E-100, polyethylene glycol 6000, citric acid, propylene glycol, vaseline oil, carmuazine, indigocarmine, hydroxypropylmethylcellulose, Opadry PINK.

Description:

Round, biconvex tablets coated with a pink color. View of the fracture: the core is brown-beige or beige with slightly expressed dark and light impregnations, odorless or with a weak specific odor.

Pharmacotherapeutic group:digestive enzyme.

ATX: & nbsp

A.09.A.A Enzyme preparations

A.09.A.A.02 Pancreatin

Pharmacodynamics:

The drug compensates for the lack of exocrine function of the pancreas.

Enzymes of amylase, lipase and protease, included in pancreatin, facilitate the digestion of carbohydrates, fats and proteins, which contributes to their more complete absorption in the small intestine.

Indications:

Insufficiency of the exocrine function of the pancreas (chronic pancreatitis, cystic fibrosis, etc.).

Chronic inflammatory-dystrophic diseases of the stomach, intestines, liver, gall bladder; condition after resection or irradiation of these organs, accompanydisturbances in the digestion of food, flatulence, diarrhea (as part of combination therapy).

To improve the digestion of food in patients with normal gastrointestinal function in the event of errors in nutrition.

Preparation for X-ray and ultrasound examinations of the abdominal cavity organs.

Contraindications:Hypersensitivity to the components of the drug, acute pancreatitis, exacerbation of chronic pancreatitis.

Carefully:

With care - cystic fibrosis.

Pregnancy and lactation:

The safety of the use of pancreatin during pregnancy is not well understood. The application is possible in cases where the expected benefit for the mother exceeds the potential risk to the fetus. It is not known whether pancreatin with breast milk, so use during lactation is not recommended.

Dosing and Administration:

The drug is taken orally, without chewing, during or after a meal.

Adults: 2-5 tablets 3-4 times a day.

In children, the drug is used as directed by a doctor. Children aged 6-7 years are prescribed 1 tablet, 8-9 years - 1-2 tablets, 10-14 years - 2 tablets 4 times a day.

The duration of treatment can vary from several days (with digestion disorders due to inaccuracies in the diet) to several months or years (if necessary, permanent replacement therapy).

Side effects:

Allergic reactions. In some cases, diarrhea, constipation, a feeling of discomfort in the stomach, nausea (the cause-and-effect relationship of the development of these reactions with the action of pancreatin is not established, since these phenomena refer to symptoms of exocrine pancreatic insufficiency).With prolonged use in high doses, it is possible to develop hyperuricosuria, an increase in the level of uric acid in the blood plasma. When using pancreatin in high doses, children may experience perianal irritation and irritation of the mucous membrane of the oral cavity. Cystic fibrosis does not recommend the use of pancreatin in high doses due to an increased risk of strictures (fibrous colonopathy) in the ileocecal region and in the ascending colon in patients.

Overdose:

Symptoms: hyperuricosuria, hyperuricemia. Children have constipation. Treatment: withdrawal of the drug, symptomatic therapy.

Interaction:

With the simultaneous use of pancreatin with iron preparations, it is possible to reduce absorption of the latter. The simultaneous use of antacid agents containing calcium carbonate and / or magnesium hydroxide, can lead to a decrease in the effectiveness of pancreatin.

Special instructions:

The dose should be adequate to the number of enzymes that are needed to absorb fat, taking into account the quality and quantity of food consumed.

Form release / dosage:Tablets, covered with enteric film coating.

Packaging:

By 10, 20,40, 50, 80,100, 800 tablets in the package.

Storage conditions:List B. In a dry, protected from light, out of reach of children, at a temperature of no higher than 25 ° C.

Shelf life:3 years. Do not use after the expiry date printed on the package.

Terms of leave from pharmacies:Without recipe

Registration number:P N001649 / 01-2002

Date of registration:29.09.2008

The owner of the registration certificate:BRYNTSALOV-A, CJSC BRYNTSALOV-A, CJSC Russia

Manufacturer: & nbsp

BRYNTSALOV-A, CJSC Russia

Information update date: & nbsp19.08.2015

Illustrated instructions

Instructions

Panzim® forte (Panzim forte)